Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum (Q34484593)

2 August 2017

Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum (English)

1 reference

(2R)-2-[(3S,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylheptane-1,5,6-triol

2 August 2017

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

(2r,6s)-6-[(3s,5r,10s,12s,13r,14r,17r)-12-Acetoxy-3-hydroxy-4,4,10,13,14-pentamethyl-7,11,15-trioxo-1,2,3,5,6,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxo-heptanoic acid

1 reference

1 reference

1 reference

1 reference

(6R)-6-[(3S,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptane-1,2,3-triol

1 reference

inferred from

reverse claim

ergosterol endoperoxide

1 reference

inferred from

reverse claim

(6R)-6-acetyloxy-6-[(3S,14R,15R)-3,15-dihydroxy-4,4,10,12,13,14-hexamethyl-7,11-dioxo-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohexanoic acid

1 reference

1 reference

(2R,6R)-6-[(3S,5R,10S,12S,13R,14R,16S,17R)-12-acetyloxy-3,16-dihydroxy-4,4,10,13,14-pentamethyl-7,11-dioxo-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid

1 reference

1 reference

1 reference

(5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R,5S)-5,6,7-trihydroxy-6-methylheptan-2-yl]-1,2,5,6,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one

1 reference

0 references

el-Mekkawy S

1

1 reference

2 August 2017

Meselhy MR

2

1 reference

2 August 2017

Nakamura N

3

1 reference

2 August 2017

Tezuka Y

4

1 reference

2 August 2017

Hattori M

5

1 reference

2 August 2017

Kakiuchi N

6

1 reference

2 August 2017

Shimotohno K

7

1 reference

2 August 2017

Kawahata T

8

1 reference

2 August 2017

Otake T

9

1 reference

2 August 2017

November 1998

3 references

16 September 2022

16 September 2022

1 reference

2 August 2017

49

1 reference

2 August 2017

1651-1657

1 reference

2 August 2017

6

1 reference

Les acides ganoderiques tàz : triterpenes cytotoxiques de Ganoderma lucidum (Polyporacée)

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2898%2900254-4

7 January 2021

The biologically active constituents of Ganoderma lucidum (Fr.) Karst. Histamine release-inhibitory triterpenes

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2898%2900254-4

7 January 2021

Anti-allergic constituents in the culture medium of Ganoderma lucidum. (I). Inhibitory effect of oleic acid on histamine release.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2898%2900254-4

7 January 2021

Anti-allergic constituents in the culture medium of Ganoderma lucidum. (II). The inhibitory effect of cyclooctasulfur on histamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2898%2900254-4

7 January 2021

Hypoglycemic actions of some heteroglycans of Ganoderma lucidum fruit bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2898%2900254-4

7 January 2021

Mechanisms of hypoglycemic activity of ganoderan B: a glycan of Ganoderma lucidum fruit bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2898%2900254-4

7 January 2021

Structures of Ganoderic Acid A and B, Two New Lanostane Type Bitter Triterpenes fromGanoderma lucidum (FR.) KARST.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2898%2900254-4

7 January 2021

Ganoderic acid G and I and ganolucidic acid A and B, new triterpenoids from Ganoderma lucidum.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2898%2900254-4

7 January 2021

Constituents of the fungus Ganoderma lucidum (Fr.) Karst. I Structures of ganoderic acids C2, E, I, and K, lucidenic acid F and related compounds.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2898%2900254-4

7 January 2021

New bitter C27 and C30 terpenoids from the fungus Ganoderma lucidum (Reishi).

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2898%2900254-4

7 January 2021

Constituents of the fungus Ganoderma lucidum (Fr.) Karst. II Structures of ganoderic acids F, G, and H, lucidenic acids D2 and E2, and related compounds.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2898%2900254-4

7 January 2021

Ganoderic acid D, E, F, and H and lucidenic acid D, E, and F, new triterpenoids from Ganoderma lucidum.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2898%2900254-4

7 January 2021

Ganoderiol A and B, new triterpenoids from the fungus Ganoderma lucidum (Reishi).

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2898%2900254-4

7 January 2021

Novel triterpenoids from the fungus Ganoderma lucidum.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2898%2900254-4

7 January 2021

Cytotoxic steroids from the mushroom Agaricus blazei

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2898%2900254-4

7 January 2021

Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2898%2900254-4

7 January 2021

A ganoderic acid derivative, a highly oxygenated lanostane-type triterpenoid from Ganoderma lucidum

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2898%2900254-4

7 January 2021

Glycyrrhizic acid inhibits virus growth and inactivates virus particles

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2898%2900254-4

7 January 2021

Anti-aids agents, 6. Salaspermic acid, an anti-HIV principle from Tripterygium wilfordii, and the structure-activity correlation with its related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2898%2900254-4

7 January 2021

Anti-AIDS agents, 9. Suberosol, a new C31 lanostane-type triterpene and anti-HIV principle from Polyalthia suberosa

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2898%2900254-4

7 January 2021

Betulinic acid derivatives: a new class of human immunodeficiency virus type 1 specific inhibitors with a new mode of action

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2898%2900254-4

7 January 2021

Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9422%2898%2900254-4

7 January 2021

New bitter C27 and C30 terpenoids from the fungus Ganoderma lucidum (Reishi).

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1271/BBB1961.49.1793

Identifiers

DOI

10.1016/S0031-9422(98)00254-4

1 reference

2 August 2017

1 reference